German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, ...

(Reuters) - Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 billion, a deal that could give it access to a recently ...

Germany’s Merck MRK-1.31%decrease; red down pointing triangle KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that ...

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be acquired by Merck & Company, Inc. (NYSE:MRK) for $47 per share in cash. The ...

Etalytics’ etaONE achieved a 21% cooling-electricity reduction in three months by autonomously orchestrating chillers, cooling towers, and pumps using real-time pressure and environmental data.

MUMBAI, India, Feb ...

Merck KGaA, the German specialty chemical and pharmaceutical company, is now cutting jobs at home. As it continues its six-month-old “Fit for 2018” program, the Darmstadt-based firm is trying to ...

– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediately add ...